FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

126161000: Methyltestosterone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
20919016 Methyltestosterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730088019 Methyltestosterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
825131000172117 méthyltestostérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methyltestosterone Is a Testosterone false Inferred relationship Some
Methyltestosterone Is a allergène médicamenteux false Inferred relationship Some
Methyltestosterone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Testicular hormone false Inferred relationship Some
Methyltestosterone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Androgen false Inferred relationship Some
Methyltestosterone Is a Steroid metabolism disorder marker (substance) true Inferred relationship Some
Methyltestosterone Is a Testosterone and/or testosterone derivative true Inferred relationship Some
Methyltestosterone Is a Testicular hormone false Inferred relationship Some
Methyltestosterone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Androgen receptor agonist (disposition) true Inferred relationship Some
Methyltestosterone Is a Anabolic androgenic steroid true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Methyltestosterone adverse reaction Causative agent (attribute) True Methyltestosterone Inferred relationship Some 1
Methyltestosterone measurement Component True Methyltestosterone Inferred relationship Some 1
Allergy to methyltestosterone (finding) Causative agent (attribute) False Methyltestosterone Inferred relationship Some
Methyltestosterone 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyltestosterone Inferred relationship Some
Methyltestosterone 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyltestosterone Inferred relationship Some
Methyltestosterone 10 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyltestosterone Inferred relationship Some
Product containing precisely esterified estrogen 625 microgram and methyltestosterone 1.25 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyltestosterone Inferred relationship Some
Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyltestosterone Inferred relationship Some
Product containing methyltestosterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 1
Product containing methyltestosterone and pemoline and yohimbine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 1
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyltestosterone Inferred relationship Some
Product containing esterified estrogen and methyltestosterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 2
Allergy to methyltestosterone (finding) Causative agent (attribute) True Methyltestosterone Inferred relationship Some 1
Methyltestosterone 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyltestosterone Inferred relationship Some 1
Methyltestosterone 10 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methyltestosterone Inferred relationship Some 1
Methyltestosterone 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyltestosterone Inferred relationship Some 1
Methyltestosterone 25 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methyltestosterone Inferred relationship Some 1
Methyltestosterone 10 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyltestosterone Inferred relationship Some 1
Methyltestosterone 10 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methyltestosterone Inferred relationship Some 1
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyltestosterone Inferred relationship Some 3
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methyltestosterone Inferred relationship Some 3
Methyltestosterone 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methyltestosterone Inferred relationship Some 1
Methyltestosterone 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methyltestosterone Inferred relationship Some 1
Methyltestosterone 10 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methyltestosterone Inferred relationship Some 1
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methyltestosterone Inferred relationship Some 3
Methyltestosterone- and pemoline- and yohimbine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 1
Methyltestosterone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 1
Esterified estrogen and methyltestosterone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 2
Product containing only methyltestosterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 1
Product containing only methyltestosterone and pemoline and yohimbine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 1
Product containing only methyltestosterone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 1
Methyltestosterone and pemoline and yohimbine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 1
Product containing precisely esterified estrogen 625 microgram and methyltestosterone 1.25 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methyltestosterone Inferred relationship Some 2
Product containing precisely esterified estrogen 625 microgram and methyltestosterone 1.25 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methyltestosterone Inferred relationship Some 2
Esterified estrogen and methyltestosterone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 2
Esterified estrogen- and methyltestosterone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyltestosterone Inferred relationship Some 2
Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methyltestosterone Inferred relationship Some 2
Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methyltestosterone Inferred relationship Some 2
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methyltestosterone Inferred relationship Some 1
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methyltestosterone Inferred relationship Some 1

This concept is not in any reference sets

Back to Start